Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1080P is a pseudogene copy of the U6 small nuclear RNA (snRNA) gene. The functional U6 snRNA is a highly conserved noncoding RNA essential for the spliceosome, the machinery responsible for removing introns from pre-mRNA during mRNA processing in eukaryotic cells[1][3]. RNU6-1080P, like other U6 snRNA pseudogenes, arose by retrotransposon-mediated duplication events (not by direct gene function)[4]. These copies are prevalent in vertebrate genomes, but they are generally non-functional: they do not contribute to splicing or other cellular activities. Their presence is an indicator of historical retrotransposition activity, and they may be used in genomics as evolutionary markers but have no established role as drug targets, biomarkers, or disease-associated entities[2][4].
No therapeutic mechanism of action as there are no drugs or interventions targeting RNU6-1080P.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1080, pseudogene (RNU6-1080P).